Wernecke K - Search Results

1

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.

Sezer O, Jakob C, Eucker J, Niemöller K, Gatz F, Wernecke K, Possinger K. Sezer O, et al. Among authors: wernecke k. Eur J Haematol. 2001 Feb;66(2):83-8. doi: 10.1034/j.1600-0609.2001.00348.x. Eur J Haematol. 2001. PMID: 11168514

2

Tumor type M2 pyruvate kinase expression in advanced breast cancer.

Lüftner D, Mesterharm J, Akrivakis C, Geppert R, Petrides PE, Wernecke KD, Possinger K. Lüftner D, et al. Among authors: wernecke kd. Anticancer Res. 2000 Nov-Dec;20(6D):5077-82. Anticancer Res. 2000. PMID: 11326672

3

Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer.

Langelotz C, Schmid P, Jakob C, Heider U, Wernecke KD, Possinger K, Sezer O. Langelotz C, et al. Among authors: wernecke kd. Br J Cancer. 2003 May 6;88(9):1406-10. doi: 10.1038/sj.bjc.6600935. Br J Cancer. 2003. PMID: 12778070 Free PMC article.

4

Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancer.

Lüftner D, Wagner K, Dingeldein G, Haas A, Sezer O, Mergenthaler HG, Wernecke KD, Possinger K. Lüftner D, et al. Among authors: wernecke kd. Anticancer Res. 1999 Jul-Aug;19(4C):3583-90. Anticancer Res. 1999. PMID: 10629656 Clinical Trial.

5

Normalisation of biochemical markers of bone formation correlates with clinical benefit from therapy in metastatic breast cancer.

Lüftner D, Richter A, Geppert R, Wernecke KD, Possinger K. Lüftner D, et al. Among authors: wernecke kd. Anticancer Res. 2003 Mar-Apr;23(2A):1017-26. Anticancer Res. 2003. PMID: 12820341

6

The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.

Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D. Pollmann D, et al. Among authors: wernecke kd. Anticancer Res. 2007 Jul-Aug;27(4A):1853-62. Anticancer Res. 2007. PMID: 17649784 Free article.

7

Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer.

Lüftner D, Mazurek S, Henschke P, Mesterharm J, Schildhauer S, Geppert R, Wernecke KD, Possinger K. Lüftner D, et al. Among authors: wernecke kd. Anticancer Res. 2003 Mar-Apr;23(2A):991-7. Anticancer Res. 2003. PMID: 12820337

8

Upregulation of HER-2/neu by ovarian ablation: results of a randomized trial comparing leuprorelin to CMF as adjuvant therapy in node-positive breast cancer patients.

Lüftner D, Jung A, Schmid P, Geppert R, Kienle E, Wernecke KD, Possinger K; Takeda Adjuvant Breast Cancer Study with Leuprorelin Study Group. Lüftner D, et al. Among authors: wernecke kd. Breast Cancer Res Treat. 2003 Aug;80(3):245-55. doi: 10.1023/a:1024911625339. Breast Cancer Res Treat. 2003. PMID: 14503797 Clinical Trial.

9

PINP as serum marker of metastatic spread to the bone in breast cancer patients.

Lüftner D, Jozereau D, Schildhauer S, Geppert R, Müller C, Fiolka G, Wernecke KD, Possinger K. Lüftner D, et al. Among authors: wernecke kd. Anticancer Res. 2005 May-Jun;25(3A):1491-9. Anticancer Res. 2005. PMID: 16033050 Free article.

10

Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing.

Luftner D, Henschke P, Kafka A, Anagnostopoulos I, Wiechen K, Geppert R, Stein H, Wernecke KD, Kreienberg R, Possinger K. Luftner D, et al. Among authors: wernecke kd. Int J Biol Markers. 2004 Jan-Mar;19(1):1-13. doi: 10.1177/172460080401900101. Int J Biol Markers. 2004. PMID: 15077921 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page